Tokyo Tape
Sign in
← Oncolys BioPharma

Annual report

4588.TEDINET S100T65H
Period2023-01-01 → 2023-12-31
Filed2024-03-29
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥63m2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥976m2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥642m2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥314m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥1.3bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥1.9bn2023-01-01 → 2023-12-31StandaloneOperating income
Operating income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥1.9bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.7bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥539m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.9bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax−¥1.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥1.9bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥1.1bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥1.6bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥2.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥912m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥2.0bnat 2023-12-31StandaloneAssets
Total assets¥2.7bnat 2022-12-31StandaloneAssets
Total assets¥4.3bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥2.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥4.4bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥567mat 2023-12-31StandaloneLiabilities
Total liabilities¥492mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.5bnat 2023-12-31StandaloneNet assets
Net assets / equity¥2.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥3.6bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥2.0bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥3.5bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.5bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥1.7bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥1.3bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2021-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.1bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.3bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.7bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥238m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥5m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥20m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥942,0002021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥38m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.1bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥114m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥3.1bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥242m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-108.922023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-145.582020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-65.552019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥74.35at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥124.2at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥206.86at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥136.43at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥240.71at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio71.5%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio81.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.4%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio78.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued19,717,100at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued14,641,900at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued14,331,300at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees34at 2023-12-31StandaloneNumber of employees
Employees33at 2022-12-31StandaloneNumber of employees
Employees33at 2021-12-31dStandaloneNumber of employees
Employees32at 2020-12-31dStandaloneNumber of employees
Employees27at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 843
ItemContextValueUnit
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember－JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember-692175000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_CapitalStockMember3623165000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_LegalCapitalSurplusMember1209590000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_CapitalSurplusMember1209590000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-3373199000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_RetainedEarningsMember-3373199000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_TreasuryStockMember-142000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember1459413000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember7680000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2159269000JPY
Issuance of new sharesCurrentYearDuration_NonConsolidatedMember1246330000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember-1938505000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember7003000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember7003000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember7003000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember-685172000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember14683000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember1474097000JPY
Income before income taxesPrior1YearDuration_NonConsolidatedMember-1146005000JPY
Income before income taxesCurrentYearDuration_NonConsolidatedMember-1935578000JPY
Depreciation and amortization ope cfPrior1YearDuration_NonConsolidatedMember914000JPY
Depreciation and amortization ope cfCurrentYearDuration_NonConsolidatedMember2286000JPY
Impairment loss ope cfPrior1YearDuration_NonConsolidatedMember4403000JPY
Impairment loss ope cfCurrentYearDuration_NonConsolidatedMember21898000JPY
Amortization of restricted stock remuneration ope cfPrior1YearDuration_NonConsolidatedMember17793000JPY
Amortization of restricted stock remuneration ope cfCurrentYearDuration_NonConsolidatedMember629000JPY
Gain on transfer of receivables ope cfPrior1YearDuration_NonConsolidatedMember-21406000JPY
Gain on transfer of receivables ope cfCurrentYearDuration_NonConsolidatedMember－JPY
Share based compensation expenses ope cfPrior1YearDuration_NonConsolidatedMember58134000JPY
Share based compensation expenses ope cfCurrentYearDuration_NonConsolidatedMember9433000JPY
Increase decrease in provision for retirement benefits ope cfPrior1YearDuration_NonConsolidatedMember1992000JPY
Increase decrease in provision for retirement benefits ope cfCurrentYearDuration_NonConsolidatedMember391000JPY
Interest and dividends income ope cfPrior1YearDuration_NonConsolidatedMember-590000JPY
Interest and dividends income ope cfCurrentYearDuration_NonConsolidatedMember-1478000JPY
Interest expenses ope cfPrior1YearDuration_NonConsolidatedMember3945000JPY
Interest expenses ope cfCurrentYearDuration_NonConsolidatedMember3602000JPY
Issuance cost of share acquisition rights ope cfPrior1YearDuration_NonConsolidatedMember－JPY
Issuance cost of share acquisition rights ope cfCurrentYearDuration_NonConsolidatedMember3029000JPY
Stock issuance cost ope cfPrior1YearDuration_NonConsolidatedMember30000JPY
Stock issuance cost ope cfCurrentYearDuration_NonConsolidatedMember8777000JPY
Foreign exchange losses gains ope cfPrior1YearDuration_NonConsolidatedMember-72723000JPY
Foreign exchange losses gains ope cfCurrentYearDuration_NonConsolidatedMember-24090000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YearDuration_NonConsolidatedMember352148000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYearDuration_NonConsolidatedMember－JPY
Decrease increase in inventories ope cfPrior1YearDuration_NonConsolidatedMember-12593000JPY
Decrease increase in inventories ope cfCurrentYearDuration_NonConsolidatedMember18907000JPY
Decrease increase in prepaid expenses ope cfPrior1YearDuration_NonConsolidatedMember14168000JPY
Decrease increase in prepaid expenses ope cfCurrentYearDuration_NonConsolidatedMember4437000JPY
Decrease increase in accounts receivable other ope cfPrior1YearDuration_NonConsolidatedMember-198392000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass